NEW YORK (GenomeWeb News) — Under two new agreements it has struck with the German company MultiSynTech, Biotage will join the peptide synthesis market, the Swedish biotech firm said today.
Through one agreement, Biotage has acquired distribution rights to all of MultiSynTech's robotic peptide synthesis systems.
The companies also will work together on a development project to design and market a microwave-aided peptide synthesis system, with the goal of increasing the yield and speed of the peptide synthesis process. The system will integrate Biotage's microwave technology with MutiSynTech's robotic synthesizer technology, the firms said. Customers for the system will include university and biopharmaceutical research groups and contract labs.
These agreements will allow Biotage, which also has operations in the US, Japan, the UK, and Germany, to offer parallel synthesis and microwave synthesis.